Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
VRCI
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
proactiveinvestors.co.uk
2 hours ago
proactiveinvestors.co.uk
4 hours ago
proactiveinvestors.co.uk
4 hours ago
proactiveinvestors.co.uk
5 hours ago
Earnings Growth
YoY
Current
Estimates
Q2.13
N/A
NA
vs NA
Q3.13
N/A
NA
vs NA
Q4.13
N/A
NA
vs NA
Q1.14
N/A
NA
vs NA
Q2.14
N/A
NA
vs NA
Q3.14
N/A
NA
vs NA
Q4.14
N/A
NA
vs NA
Q1.15
N/A
NA
vs NA
Q2.15
N/A
NA
vs NA
Q3.15
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q2.13
-100%
NA vs 30.8K
Q3.13
-100%
NA vs 73.5K
Q4.13
-100%
NA vs 49.6K
Q1.14
-100%
NA vs 75.9K
Q2.14
NA
NA vs NA
Q3.14
NA
NA vs NA
Q4.14
NA
NA vs NA
Q1.15
NA
NA vs NA
Q2.15
NA
NA vs NA
Q3.15
NA
NA vs NA
Return on Equity
QoQ
Q2.13
+193%
1.93
vs -0.06
Q3.13
+97%
0.97
vs 1.93
Q4.13
+47%
0.47
vs 0.97
Q1.14
+158%
1.58
vs 0.47
Q2.14
+178%
1.78
vs 1.58
Q3.14
+59%
0.59
vs 1.78
Q4.14
+11%
0.11
vs 0.59
Q1.15
+10%
0.1
vs 0.11
Q2.15
+38%
0.38
vs 0.1
Q3.15
+10%
0.1
vs 0.38
Institutionnal Ownership
N/A
Q3.23
NA
NA
vs NA
NA
Q4.23
NA
NA
vs NA
NA
Q1.24
NA
NA
vs NA
NA
Q2.24
NA
NA
vs NA
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
NA
NA
vs NA
NA
Q1.25
NA
NA
vs NA
NA
Q2.25
NA
NA
vs NA
NA
Q3.25
NA
NA
vs NA
NA
Q4.25
NA
NA
vs NA
NA
Relative Strength
VRCI
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Verde Science, Inc., a pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions. The company was formerly known as Rango Energy, Inc. and changed its name to Verde Science, Inc. in May 2014. Verde Science, Inc. was founded in 2007 and is based in Dallas, Texas.
OTC
Relative Strenght
Volume Buzz
242%
Earning Acce
No
Dist 52w H.
0%Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available